NEW YORK (GenomeWeb) – Canadian life sciences company DiagnoCure yesterday reported that its fourth quarter revenues declined to C$109,831 from C$122,254 year over year on lower royalties tied to its PCA3 biomarker.

The company reported a net loss of C$2.4 million, or C$.05 per share, in the fourth quarter, up sharply from a loss of C$461,710, or C$.01 per share, for Q4 2014.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.